The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis

The long-range goal of this project is to investigate the protective effects of conjugated linoleic acid (CLA) against carcinogenesis. In this dissertation, we demonstrate the mechanisms of CLA action on cell cycle progression and repression of polycyclic aromatic hydrocarbon (PAH)-induced Cyclooxy...

Full description

Bibliographic Details
Main Author: Kemp, Michael Quentin
Other Authors: Romagnolo, Donato F.
Language:EN
Published: The University of Arizona. 2005
Subjects:
CLA
p53
AhR
Online Access:http://hdl.handle.net/10150/193637
id ndltd-arizona.edu-oai-arizona.openrepository.com-10150-193637
record_format oai_dc
spelling ndltd-arizona.edu-oai-arizona.openrepository.com-10150-1936372015-10-23T04:39:43Z The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis Kemp, Michael Quentin Romagnolo, Donato F. Romagnolo, Donato F. Howell, Wanda Houtkooper, Linda Going, Scott Winzerling, Joy CLA Breast cancer p53 AhR B[a]P The long-range goal of this project is to investigate the protective effects of conjugated linoleic acid (CLA) against carcinogenesis. In this dissertation, we demonstrate the mechanisms of CLA action on cell cycle progression and repression of polycyclic aromatic hydrocarbon (PAH)-induced Cyclooxygenase-2 (COX-2) in breast and colon cancer cells. CLA reduced the expression of factors required for G1 to S-phase transition including cyclins D1 and E, and hyperphoshorylated retinoblastoma Rb protein. In contrast, the over-expression of mutant p53 (175Arg to His) in MCF-7 cells prevented the CLA-dependent accumulation of p21 and the reduction of cyclin E levels suggesting that the expression of wild-type p53 is required for CLA-mediated activation of the G1 restriction point. We also report, CLA reduced the expression of COX-2 promoter activity induced by the aromatic hydrocarbon receptor (AhR)-ligand benzo[a]pyrene (B[a]P). Mutagenesis or deletion of potential xenobiotic responsive elements (XREs) within the COX-2 promoter abrogated its ability to be induced by the high affinity AhR-ligand TCDD. In addition, promoter studies using a XRE-dependent CYP1A1 plasmid revealed CLA can inhibit PAH-induced AhR/XRE-driven genes. In both studies, the t10,c12-CLA isomer was more effective than c9,t11-CLA in inhibiting cell proliferation and AhR/XRE-dependent genes. Taken together, these data suggest that the anti-cancerous properties of CLA appear to be a function, at least in part, of the relative content of specific isomers and their 1) ability to elicit a p53 response that leads to the accumulation of pRb and cell growth arrest, and 2) ability to inhibit PAH-induced cyclooxygenase-2 promoter activity through an AhR-dependent mechanism. 2005 text Electronic Dissertation http://hdl.handle.net/10150/193637 137355222 1357 EN Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. The University of Arizona.
collection NDLTD
language EN
sources NDLTD
topic CLA
Breast cancer
p53
AhR
B[a]P
spellingShingle CLA
Breast cancer
p53
AhR
B[a]P
Kemp, Michael Quentin
The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
description The long-range goal of this project is to investigate the protective effects of conjugated linoleic acid (CLA) against carcinogenesis. In this dissertation, we demonstrate the mechanisms of CLA action on cell cycle progression and repression of polycyclic aromatic hydrocarbon (PAH)-induced Cyclooxygenase-2 (COX-2) in breast and colon cancer cells. CLA reduced the expression of factors required for G1 to S-phase transition including cyclins D1 and E, and hyperphoshorylated retinoblastoma Rb protein. In contrast, the over-expression of mutant p53 (175Arg to His) in MCF-7 cells prevented the CLA-dependent accumulation of p21 and the reduction of cyclin E levels suggesting that the expression of wild-type p53 is required for CLA-mediated activation of the G1 restriction point. We also report, CLA reduced the expression of COX-2 promoter activity induced by the aromatic hydrocarbon receptor (AhR)-ligand benzo[a]pyrene (B[a]P). Mutagenesis or deletion of potential xenobiotic responsive elements (XREs) within the COX-2 promoter abrogated its ability to be induced by the high affinity AhR-ligand TCDD. In addition, promoter studies using a XRE-dependent CYP1A1 plasmid revealed CLA can inhibit PAH-induced AhR/XRE-driven genes. In both studies, the t10,c12-CLA isomer was more effective than c9,t11-CLA in inhibiting cell proliferation and AhR/XRE-dependent genes. Taken together, these data suggest that the anti-cancerous properties of CLA appear to be a function, at least in part, of the relative content of specific isomers and their 1) ability to elicit a p53 response that leads to the accumulation of pRb and cell growth arrest, and 2) ability to inhibit PAH-induced cyclooxygenase-2 promoter activity through an AhR-dependent mechanism.
author2 Romagnolo, Donato F.
author_facet Romagnolo, Donato F.
Kemp, Michael Quentin
author Kemp, Michael Quentin
author_sort Kemp, Michael Quentin
title The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
title_short The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
title_full The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
title_fullStr The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
title_full_unstemmed The Protective Effects of Conjugated Linoleic Acid Against Carcinogenesis
title_sort protective effects of conjugated linoleic acid against carcinogenesis
publisher The University of Arizona.
publishDate 2005
url http://hdl.handle.net/10150/193637
work_keys_str_mv AT kempmichaelquentin theprotectiveeffectsofconjugatedlinoleicacidagainstcarcinogenesis
AT kempmichaelquentin protectiveeffectsofconjugatedlinoleicacidagainstcarcinogenesis
_version_ 1718099016447688704